Pfizer-biontech covid-19 vaccine comirnaty® receives full u.s. fda approval for individuals 16 years and older

New york, usa and mainz, germany, august 23, 2021 — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the u.s. food and drug administration (fda) approved the biologics license application (bla) for comirnaty® (covid-19 vaccine, mrna) to prevent covid-19 in individuals 16 years of age and older. comirnaty is the first covid-19 vaccine to be granted approval by the fda.
BNTX Ratings Summary
BNTX Quant Ranking